Hilda Scharen-Guivel - 14 Oct 2022 Form 4 Insider Report for IRADIMED CORP (IRMD)

Role
Director
Signature
/s/ Hilda Scharen-Guivel
Issuer symbol
IRMD
Transactions as of
14 Oct 2022
Net transactions value
$0
Form type
4
Filing time
18 Oct 2022, 18:52:14 UTC
Previous filing
13 Oct 2022
Next filing
23 Oct 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRMD Restricted Stock Units Award $0 +5,300 $0.000000 5,300 14 Oct 2022 Common Stock 5,300 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock.
F2 The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in three equal annual installments beginning on October 14, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.